Acutus Medical Secures FDA Clearance and CE Mark for SuperMap™

Announces First Procedures in U.S. and Initial Experience in EU

Acutus Medical today announced FDA clearance and CE Mark of SuperMap™ – a revolutionary addition to its AcQMap 3D Imaging and Mapping System. SuperMap is a high-fidelity, high-resolution mapping algorithm for both stable and transient arrhythmias. SuperMap’s user interface effortlessly guides electrophysiologists to quickly create exquisitely detailed whole-chamber maps of the left or right atrium using its unique non-contact roving “hover-map” approach.

This allows electrophysiologists to diagnose and treat arrhythmia patients rapidly, consistently and potentially more effective.  Adding the SuperMap mode to the AcQMap system enables users to visualize any atrial rhythm in under three minutes. Rapidly mapping and re-mapping the whole heart chamber facilitates a new procedural workflow in EP ablation — by making it practical to execute an iterative “map, ablate, re-map” approach to diagnosis and therapy.

With this groundbreaking addition, Acutus Medical delivers the only EP imaging and mapping system to offer three mapping modalities: contact mapping, non-contact mapping, and non-contact hover mapping — known as SuperMap.

Initial Experience EU*: “In less than three minutes, the AcQMap System can map the entire chamber to clearly identify re-entrant circuits, regions of slow conduction and focal origins. The Automatic Beat Grouping algorithm of SuperMap is helpful to map alternating or changing atrial tachycardias by categorizing and displaying multiple tachycardias occurring at the same time,” said Dr. Tom Wong, Electrophysiologist, Royal Brompton & Harefield NHS Foundation Trust, London, England.

“Dynamic atrial substrate characterization is an emerging diagnostic strategy involving the mapping of sinus and paced rhythms to identify clinically relevant areas of slow conduction, lines of block and critical zones of irregular activity. These areas may correlate with arrhythmia initiation or maintenance. SuperMap is the ideal tool for implementing this strategy. Within seconds, I can review the maps and identify zones of slow conduction,” said Dr. Gian-Battista Chierchia, Electrophysiologist, Vrije Universiteit Brussel, Brussels, Belgium.

First Cases in the U.S.:  “It is critical to map repetitive rhythms in patients with irregular heartbeats. This approach is extremely helpful in identifying areas of low amplitude which may indicate scar. I am looking forward to integrating new technology into my workflow for the treatment of any arrhythmia,” stated Gregory Feld, MD, Professor of Medicine at UC San Diego School of Medicine and director of the Cardiac Electrophysiology Program at UC San Diego Health.

“We recently completed an extraordinary case with the Acutus system and SuperMap. We captured three whole-chamber maps, targeted three ablation sites, and the patient left in sinus rhythm — all in the span of one hour,” said Arjun Gururaj, MD, Electrophysiologist, Nevada Heart & Vascular Center in Las Vegas, Nevada. “These are notoriously complex atrial tachycardias that the EP community knows about. SuperMap can show potential sources and likely mechanisms in those complex cases in minutes as opposed to hours with conventional systems — because we are seeing things that we couldn’t see before.  Now we may be able to do something about it in far less time with better acute results. It has amazing potential.”

Vince Burgess, President & CEO of Acutus Medical commented, “We have invested heavily in developing a unique, multifunctional mapping system that provides physicians with the visual information needed to effectively diagnose and treat patients. With three distinct and unique mapping modalities in one system, physicians can feel confident in tackling any atrial arrhythmia accurately and efficiently. We are committed to improving patient outcomes, expediting procedures times and further developing our full suite of products for the global electrophysiology community.”

*The AcQMap System with SuperMap was CE Marked in October of 2019.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution